D
Lexaria Bioscience Corp. LEXX
$1.35 $0.032.27%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

11/30/2024 08/31/2024 05/31/2024 02/29/2024 11/30/2023
Net Income -7.32M -5.80M -4.85M -5.44M -6.09M
Total Depreciation and Amortization 109.10K 108.80K 165.60K 179.30K 191.80K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 634.40K 621.00K 777.70K 430.20K 421.10K
Change in Net Operating Assets 72.80K 106.50K -782.50K -378.80K -342.20K
Cash from Operations -6.50M -4.96M -4.69M -5.21M -5.82M
Capital Expenditure -67.60K -43.00K 0.00 0.00 -13.20K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -118.80K -145.60K -187.40K -199.00K -161.40K
Cash from Investing -186.40K -188.60K -187.40K -199.00K -174.70K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 12.84M 10.32M 10.32M 6.98M 3.53M
Repurchase of Common Stock -- -- -121.70K -121.70K -121.70K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 12.84M 10.32M 10.19M 6.86M 3.42M
Foreign Exchange rate Adjustments -27.30K -19.70K -21.80K -20.60K 4.40K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 6.12M 5.15M 5.30M 1.43M -2.58M
Weiss Ratings